A trial looking at sorafenib in skin schwannomas

This trial is looking at how sorafenib (Nexavar) works in schwannomas of the skin.

Skin schwannomas are non cancerous (benign) tumours that may develop on the skin of people who have a condition called neurofibromatosis type 2 (NF 2). NF 2 is a condition that is caused by changes in the genes in the body’s cells. People with NF 2 have an increased risk of developing certain types of tumours. Neurofibromatosis is difficult to treat and doctors are looking for new ways to manage it.